Establishment Labs Holdings (ESTA) EPS (Diluted) Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) EPS (Diluted) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 2.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.62% |
| Dec 31, 2025 | 45.80% |
| Sep 30, 2025 | 20.86% |
| Jun 30, 2025 | 27.74% |
| Mar 31, 2025 | -42.26% |
| Dec 31, 2024 | -27.47% |
| Sep 30, 2024 | 1.03% |
| Jun 30, 2024 | -40.45% |
| Mar 31, 2024 | -25.98% |
| Dec 31, 2023 | -49.04% |
| Sep 30, 2023 | -84.24% |
| Jun 30, 2023 | -13.60% |
| Mar 31, 2023 | 17.58% |
| Dec 31, 2022 | -27.04% |
| Sep 30, 2022 | -7.01% |
| Jun 30, 2022 | -50.16% |
| Mar 31, 2022 | 23.05% |
| Dec 31, 2021 | -4.25% |
| Sep 30, 2021 | -124.98% |
| Jun 30, 2021 | 28.48% |